The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

RXi Pharmaceuticals - Discovering and Developing Therapeutics Based on its Self-Delivering RNAi (sd-rxRNA®) Platform and Immunotherapy Agents

SNNLive spoke with Dr. Geert Cauwenbergh, President & CEO of RXi Pharmaceuticals Corporation (NASDAQ: RXII) at the Dawson James Small Cap Growth Conference 2015 in Jupiter, FL.

Share With

Tuesday, October 27, 2015

   

© 2017 Stock News Now